NCT06286033View on ClinicalTrials.gov

Single and Multiple Ascending Dose Study and Food Effect Study for AG181

PHASE1RecruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

AG-181

AG-181 tablets

DRUG

Placebo

AG-181 matched-placebo tablets

Trial Locations (1)

84124

RECRUITING

ICON 1255 East 3900 South, Salt Lake City

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY